Neuberger Berman Group LLC Intra Cellular Therapies, Inc. Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q1 2024
A detailed history of Neuberger Berman Group LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 81,816 shares of ITCI stock, worth $6.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,816Holding current value
$6.26 Million% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ITCI
# of Institutions
385Shares Held
77.5MCall Options Held
1.7MPut Options Held
1.13M-
Vanguard Group Inc Valley Forge, PA9.23MShares$706 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.08MShares$618 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$295 Million1.4% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.82MShares$216 Million3.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.48MShares$189 Million2.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.22B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...